Introduction to Biologic and Biosimilar Product Development and Analysis / by Karen M. Nagel.
By: Nagel, Karen M., autor
Contributor(s): SpringerLink (Online service)
Series: (AAPS Introductions in the Pharmaceutical Sciences, 2522-834X); (Biomedical and Life Sciences (Springer-11642)).Publisher: Cham, Switzerland : Springer International Publishing, 2018Description: 1 recurso en línea (XI, 109 páginas 4 ilustraciones a color).ISBN: 9783319984285.Subject: Industria farmacéuticaOnline resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)
| Item type | Current library | Collection | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | RS380 RS190 EB (Browse shelf(Opens below)) | Acceso electrónico | eBook.26112149 |
Browsing Madrid Digital shelves, Shelving location: Acceso Electrónico (UEM) Close shelf browser (Hides shelf browser)
| RS380 .P43 2013 EB Pharmaceutical Biotechnology : Fundamentals and Applications | RS380 .P733 2015 EB Practical Pharmaceutics : An International Guideline for the Preparation, Care and Use of Medicinal Products | RS380 .Q355 2015 EB Quality by Design for Biopharmaceutical Drug Product Development | RS380 RS190 EB Introduction to Biologic and Biosimilar Product Development and Analysis | RS380 RS190 EB Regulation of Heat Shock Protein Responses | RS380 .W35 2007 EB Pharmaceutical biotechnology : concepts and applications | RS400 2021 EB Ophthalmic Product Development : From Bench to Bedside |
Recombinant DNA Technology -- Therapeutic Proteins -- Therapeutic Antibodies -- Analysis and Regulation of Biologics including Biosimilars.
The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduction to Biologic and Biosimilar Product Development and Analysis, will deal only with peptides, proteins and monoclonal antibodies.
There are no comments on this title.